Alerts will be sent to your verified email
Verify EmailSHAMROIN
|
Shamrock Indl. Co
|
Parmax Pharma
|
Ortin Global
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
0.0 | 24.13 % | 1.67 % |
|
5yr average Equity Multiplier
|
1.02 | 29.23 | 2.06 |
|
5yr Average Asset Turnover Ratio
|
0.0 | 1.05 | 0.28 |
|
5yr Avg Net Profit Margin
|
0.0 | -11.29 % | -124.59 % |
|
Price to Book
|
10.25 | 0.0 | 9.24 |
|
P/E
|
0.0 | 0.0 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | -92.25 Days | 1016.26 Days |
|
Inventory Days
|
0.0 | 69.37 Days | 326.59 Days |
|
Days Receivable
|
0.0 | 20.01 Days | 1081.4 Days |
|
Days Payable
|
0.0 | 296.94 Days | 645.07 Days |
|
5yr Average Interest Coverage Ratio
|
0.0 | -0.77 | -64.13 |
|
5yr Avg ROCE
|
-8.65 % | -14.3 % | -34.49 % |
|
5yr Avg Operating Profit Margin
|
0.0 | 2.43 % | -107.87 % |
|
5 yr average Debt to Equity
|
0.0 | 10.96 | 0.51 |
|
5yr CAGR Net Profit
|
-15.95 % | n/a | n/a |
|
5yr Average Return on Assets
|
-8.47 % | -9.05 % | -25.0 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
43.36 % | 30.8 % | 1.23 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.38 % | 0.0 | -20.28 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Shamrock Indl. Co
|
Parmax Pharma
|
Ortin Global
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|